Logo | Name | Σ | ||
---|---|---|---|---|
Innovaud The innovation and investment promotion agency for the canton of Vaud, in Switzerland. Innovaud is the innovation and investment promotion agency for the canton of Vaud, in Switzerland’s Lake Geneva region. We help tech-oriented companies develop their businesses and carry out innovation projects. We assist foreign companies wanting to set up in our region. innovation, sciences de la vie, nouvelles technologies, industrie de précision, accompagnement de start-up et de PME, cleantech, technologies de l'information et de communication, investir, high-tech, innovation hub, Europe, Switzerland, Suisse, Vaud, and #VDTech | 397 | 120 | 332 | |
Air Liquide Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902. Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. … | 1432 | 1078 | 330 | |
Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1562 | 1422 | 60 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1757 | 1562 | 123 | |
NHS England We lead and support the NHS in England to deliver improved care for patients. We work with NHS Improvement to act as a single organisation to better support the NHS to deliver improved care for patients: https://www.england.nhs.uk/comment-policy NHS England is increasing transparency in the NHS and improving services for patients. We work with NHS staff, patients, stakeholders and the public to improve the health outcomes for people in England. We are responsible for the stewardship of £99 billion of public funds to provide comprehensive health and care services available to all, where there is clinical need and regardless of an … Sectors: Insurance | 2033 | 1724 | 93 | |
Illumina For Startups Illumina for Startups supporting genomics and multi-omics startups across the globe. Illumina for Startups Network aims to inspire the creation, funding, and growth of genomics and multi-omics startups across the globe. It is designed for the entrepreneurial ecosystem and focused on building connections, strengthening community, and advancing breakthrough genomics applications. Current Illumina for Startups initiatives include Startups Grants for founders to work with Illumina sites to run proof-of-concept sequencing experiments. For more information visit https://www.illumina.com/company/illumina-for-startups.html Past initiatives include Illumina Accelerator, company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK. Illumina Accelerator … Sectors: Biotechnology Startup accelerator & VC | 917 | 456 | 155 | |
AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3777 | 2612 | 203 | |
Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: Biotechnology Pharmaceutical | 263 | 187 | 35 | |
UK Research and Innovation Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves … Sectors: Public business cluster | 4038 | 2858 | 695 | |
Cisco Cisco (NASDAQ: CSCO) enables people to make powerful connections--whether in business, education, philanthropy, or creativity. Cisco hardware, software, and service offerings are used to create the Internet solutions that make networks possible--providing easy access to information anywhere, at any time. Cisco was founded in 1984 by a small group of computer scientists from Stanford University. Since the company's inception, Cisco engineers have been leaders in the development of Internet Protocol (IP)-based networking technologies. Today, with more than 70,000 employees worldwide, this tradition of innovation continues with industry-leading products and solutions in the company's core development areas of routing and switching, … Sectors: IT services | 8723 | 5743 | 574 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2107 | 1855 | 189 | |
UK Export Finance We help UK companies of all sizes win contracts, fulfil orders and get paid. UK Export Finance is the UK’s export credit agency and a government department, working alongside the Department for Business and Trade as an integral part of its strategy and operations. Our mission is to advance prosperity by ensuring no viable UK export fails for lack of finance or insurance, doing that sustainably and at no net cost to the taxpayer. We help UK companies of all sizes and in all sectors win, fulfil and get paid for export contracts. Export finance and insurance Sectors: National and local authorities | 3583 | 2698 | 448 | |
KPMG KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We have 273,000 outstanding professionals working together to deliver value in 143 countries and territories. With a worldwide presence, KPMG continues to build on our successes thanks to clear vision, defined values and, above all, our people. Our industry focus helps KPMG firms’ professionals develop a rich understanding of clients' businesses and the insight, skills and resources required to address industry-specific issues and opportunities. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm … Sectors: Consulting, audit | 6425 | 5450 | 666 | |
Gimv Building Leading Companies for the benefit of our economy and society. Gimv is a European investment company with more than 40 years' experience in private equity. Listed on Euronext Brussels, Gimv currently has EUR 1.5 billion of assets under management. The portfolio contains around 60 portfolio companies, with a combined turnover of EUR 3.7 billion and more than 20,000 employees. As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s five investment platforms are: Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable … | 112 | 43 | 63 | |
London Stock Exchange The London Stock Exchange is at the heart of where ideas meet capital and become reality. Home to nearly 2,000 companies from over 100 countries, with a combined value of £4.8 trillion. Whether you’re a business seeking greater horizons, a government with an ambitious sustainability agenda, a pension fund seeking returns for your client, we provide the flexibility to make the connections you need to create real impact. We offer our customers extensive access to capital markets and liquidity across multiple asset classes. We operate a broad range of international equity, fixed income and exchange traded products. The London Stock … Sectors: Finance | 1684 | 1073 | 189 | |
Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: Pharmaceutical | 1658 | 1073 | 127 | |
IBM At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you. We're here to help every creator turn their "what if" into what is. Let's create something that will change everything. Cloud, Mobile, Cognitive, Security, Research, Watson, Analytics, Consulting, Commerce, Experience Design, Internet of Things, Technology support, Industry solutions, Systems services, Resiliency services, Financing, and IT infrastructure Sectors: IT services | 15810 | 10679 | 536 |